Securities Fraud Lawsuit Filed Against Fennec Pharmaceuticals (FENC)


A securities fraud lawsuit has been filed against Fennec Pharmaceuticals, Inc. (NASDAQ: FENC) for potential securities violations on behalf of shareholders who purchased shares anytime during the period from May 28, 2021 through November 26, 2021.  The release of potentially misrepresentative and misleading information, as well as failure to disclose material adverse facts to the […]